,
your personalized virtual assistant to find clinical trials. Go head, 
Karyn Okai
Investigational SiteMissoula, Montana - 59802 (406-329-7029) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS3
- SINCE2009
An Open-Label Study of Trastuzumab-MCC-DM1 (T-DM1) vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer
March 2009 - August 2013
Breast Neoplasms
Capecitabine
Lapatinib
Trastuzumab-Mcc-Dm1
